SP (Specialty Pharmacy Data)
Specialty pharmacy data is distinct from traditional PRx data because it covers a narrower but clinically significant patient population. Specialty drugs, including biologics, oncology therapies and rare disease treatments, are often only available through limited distribution networks or exclusive specialty pharmacy hubs. SP data captures dispensing, patient support program enrollment, adherence and persistence patterns for these therapies, making it essential for launch tracking and patient journey analysis in complex disease areas.
TL;DR
SP refers to data from specialty pharmacies, the dispensing channels that handle complex, high cost, or restricted medications like biologics and oncology therapies.
CATEGORY
Abbreviations
WHO IT IMPACTS
Life sciences companies in oncology, rare disease, immunology, and other specialty therapeutic areas; market access teams; patient services teams; and outcomes researchers working with high-cost or limited-distribution therapies.
RELATED TERMS
PRx (Traditional Pharmacy Data)DEFINITION
SP refers to data sourced from specialty pharmacies – dispensing channels that handle complex, high-cost or otherwise restricted medications that require special handling, storage, administration or patient monitoring.
WHY IT MATTERS
- Captures a narrower but clinically critical patient population not well represented in traditional PRx data
- Tracks dispensing through limited distribution networks and specialty hubs where mainstream retail data has little visibility
- Reveals patient support program enrollment, adherence, and persistence patterns essential for complex therapies
- Critical for launch tracking and patient journey analysis in oncology, rare disease, immunology, and other specialty areas
Example: A life sciences team launching a new biologic for rheumatoid arthritis would track SP data to monitor patient starts, time-to-fill and refill rates – metrics that are largely invisible in traditional PRx channels.